Cancer antigen-125 is a predictor of mortality in patients with pulmonary arterial hypertension

Sahin A., Kaya H., Avcı O.

CLINICAL BIOCHEMISTRY, vol.89, pp.58-62, 2021 (SCI-Expanded) identifier

  • Publication Type: Article / Article
  • Volume: 89
  • Publication Date: 2021
  • Doi Number: 10.1016/j.clinbiochem.2020.14.010
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, CAB Abstracts, EMBASE, MEDLINE, Veterinary Science Database
  • Page Numbers: pp.58-62
  • Keywords: Pulmonary arterial hypertension, CA 125 antigen, Mortality, Biomarker
  • Çanakkale Onsekiz Mart University Affiliated: Yes


Background: Carbohydrate antigen 125 (CA 125), known as a tumor marker for ovarian cancer, has been reported to increase and be associated with severity in heart failure and chronic obstructive pulmonary disease. Patients with pulmonary arterial hypertension may also die due to developing right heart failure. The aim of this study is to evaluate the prognostic role of CA-125 in PAH patients.